Reducing the complexity of Regulatory submissions, the global Regulatory Authorities transformed all the submissions from paper to electronic format. Respectively, there are several electronic submission formats proposed by country-specific Regulatory bodies. Recently, the US FDA issued a new guidance for electronic submission for medical devices, following a draft guidance issued in September 2019.
